Published in Addiction on October 05, 2009
Formalizing the role of agent-based modeling in causal inference and epidemiology. Am J Epidemiol (2014) 2.08
An agent-based model of income inequalities in diet in the context of residential segregation. Am J Prev Med (2011) 1.59
A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies. PLoS One (2012) 1.09
"I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids. Int J Drug Policy (2012) 0.97
Qualitative social research in addictions publishing: Creating an enabling journal environment. Int J Drug Policy (2010) 0.92
Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative. AIDS Behav (2016) 0.79
From monocausality to systems thinking: a complementary and alternative conceptual approach for better understanding the development and prevention of sports injury. Inj Epidemiol (2015) 0.78
A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems. BMC Health Serv Res (2016) 0.75
Effects of a sustained heroin shortage in three Australian States. Addiction (2005) 6.62
Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics. Drug Alcohol Rev (2005) 4.02
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14
Comparative assessment of transport risks--how it can contribute to health impact assessment of transport policies. Bull World Health Organ (2003) 2.32
A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction (2002) 2.20
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog (2011) 2.13
Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust (2005) 2.11
Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs. Drug Alcohol Rev (2012) 2.06
Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction (2005) 1.86
Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis (2011) 1.74
The oral health of street-recruited injecting drug users: prevalence and correlates of problems. Addiction (2008) 1.71
'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction (2013) 1.56
The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction (2010) 1.51
Alcohol's involvement in recurrent child abuse and neglect cases. Addiction (2012) 1.47
'Wide-awake drunkenness'? Investigating the association between alcohol intoxication and stimulant use in the night-time economy. Addiction (2014) 1.43
A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia. Addiction (2003) 1.41
"Let's get Wasted!" and Other Apps: Characteristics, Acceptability, and Use of Alcohol-Related Smartphone Applications. JMIR Mhealth Uhealth (2013) 1.40
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol (2012) 1.39
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia. Med J Aust (2012) 1.33
Alcohol-related negative consequences among drinkers around the world. Addiction (2011) 1.33
Surveying alcohol and other drug use through telephone sampling: a comparison of landline and mobile phone samples. BMC Med Res Methodol (2013) 1.32
Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction (2009) 1.22
Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend (2011) 1.21
High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend (2012) 1.20
Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis (2013) 1.19
How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18
Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open (2013) 1.18
Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis (2012) 1.13
When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend (2006) 1.12
Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction (2007) 1.12
Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS (2012) 1.11
Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning. Addiction (2009) 1.10
Injection drug users' involvement in drug dealing in the downtown eastside of Vancouver: social organization and systemic violence. Int J Drug Policy (2013) 1.09
Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend (2007) 1.08
The ethics of paying drug users who participate in research: a review and practical recommendations. J Empir Res Hum Res Ethics (2006) 1.07
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS One (2012) 1.07
The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care (2012) 1.05
Intranasal naloxone for the treatment of suspected heroin overdose. Addiction (2008) 1.04
The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. J Acquir Immune Defic Syndr (2009) 1.04
Individual and community correlates of young people's high-risk drinking in Victoria, Australia. Drug Alcohol Depend (2008) 1.03
Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results. Harm Reduct J (2013) 1.02
Women, work and musculoskeletal health. Soc Sci Med (2004) 1.01
A prospective study of hepatitis C incidence in Australian prisoners. Addiction (2014) 0.99
Hepatitis C transmission and treatment in contact networks of people who inject drugs. PLoS One (2013) 0.98
Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr (2008) 0.97
Know your limits: awareness of the 2009 Australian alcohol guidelines among young people. Drug Alcohol Rev (2011) 0.97
Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health (2008) 0.97
Social demography of alcohol-related harm to children in Australia. Addiction (2012) 0.97
The effectiveness of harm reduction in preventing HIV among injecting drug users. N S W Public Health Bull (2010) 0.96
Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. Am J Public Health (2013) 0.95
Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev (2006) 0.94
Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health (2013) 0.93
Biomarker validation of recent unprotected sexual intercourse in a prospective study of young women engaged in sex work in Phnom Penh, Cambodia. Sex Transm Dis (2013) 0.93
Outreach for chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health (2013) 0.92
Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice. Drug Alcohol Rev (2005) 0.92
The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol (2009) 0.92
Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health (2008) 0.91
An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011. Int J Drug Policy (2012) 0.91
Alcohol use and risk taking among regular ecstasy users. Subst Use Misuse (2006) 0.91
Time of Day and Day of Week Trends in EMS Demand. Prehosp Emerg Care (2015) 0.90
Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Aust N Z J Public Health (2008) 0.90
The Indigenous Resiliency Project: a worked example of community-based participatory research. N S W Public Health Bull (2009) 0.89
Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions. Drug Alcohol Rev (2008) 0.89
Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events. J Subst Abuse Treat (2008) 0.88
A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med (2013) 0.88
Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney. Drug Alcohol Rev (2010) 0.88
Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduct J (2005) 0.88
Injecting-related injury and disease among clients of a supervised injecting facility. Drug Alcohol Depend (2009) 0.88
Drugs, public health and policing in indigenous communities. Drug Alcohol Rev (2004) 0.87
The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia. Int J Drug Policy (2010) 0.87
HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment. J Acquir Immune Defic Syndr (2015) 0.86
Violence prevention and municipal licensing of indoor sex work venues in the Greater Vancouver Area: narratives of migrant sex workers, managers and business owners. Cult Health Sex (2015) 0.86
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial. Am J Addict (2004) 0.86
Mental health symptoms among street-based psychostimulant injectors in Sydney's Kings Cross. Subst Use Misuse (2010) 0.86
A research routine to assess bias introduced by low response rates in postal surveys. Nurse Res (2009) 0.86
Individual-level syringe coverage among Needle and Syringe Program attendees in Australia. Drug Alcohol Depend (2011) 0.85
Using ambulance attendances to recruit people who have experienced non-fatal heroin overdose. Drug Alcohol Depend (2002) 0.85
Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Int J Drug Policy (2007) 0.85
Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008. Int J Drug Policy (2010) 0.85
HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment. Curr Opin HIV AIDS (2012) 0.85
STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia. BMC Infect Dis (2013) 0.85
The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing. Drug Alcohol Depend (2012) 0.85
Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified. Drug Alcohol Rev (2007) 0.85
Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review. Drug Alcohol Rev (2009) 0.84
Disturbingly low levels of contraception among women living with hepatitis C. Aust N Z J Public Health (2003) 0.84
Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009. AIDS (2011) 0.84
Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs. Drug Alcohol Depend (2011) 0.84
Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction. AIDS (2014) 0.84
The impact of khat use on East African communities in Melbourne: a preliminary investigation. Drug Alcohol Rev (2011) 0.84
The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting. Resuscitation (2005) 0.84
From oxycodone to heroin: two cases of transitioning opioid use in young Australians. Drug Alcohol Rev (2013) 0.83
Are people who inject performance and image-enhancing drugs an increasing population of Needle and Syringe Program attendees? Drug Alcohol Rev (2012) 0.83
The effect of timing when seeking permission to access personal health services utilization records. Ann Epidemiol (2002) 0.83
Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity. Cult Health Sex (2008) 0.83
HIV and HCV among people who inject drugs in Central Asia. Drug Alcohol Depend (2013) 0.83
High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. Addiction (2014) 0.83
Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia. Addict Sci Clin Pract (2012) 0.83